PARTNER WITH US
Forge a Strategic Partnership with the Liquid Biopsy for Precision Medicine Summit Europe!
The inaugural Liquid Biopsy for Precision Medicine Summit Europe is industry’s sole event exclusively focused on utilizing liquid biopsies, dedicated to showcasing latest innovations, leading expertis and forging new connections.
As demand increases to harness liquid biopsies for personalized medicine, 60+ leaders and innovators in Precision Medicine, Diagnostics, Oncology, Translational, Biomarkers & Regulatory Affairs will gather to divulge the next cornerstone of cancer care.
Designed with collaboration in mind, this is your opportunity to showcase your expertise, capabilities and developments to a diverse group of industry KOLs and drug development decision makers actively seeking their next partner.
If you have capabilities in liquid biopsy assay development, CRO partnerships, diagnostics, NGS and sequencing, omic platforms, AI/bioinformatics or clinical diagnostics, this is your unmatched opportunity to brush shoulders with industry experts and generate long-term commercial partnerships.
Our Liquid Biopsy community of attendees highlighted the need for capabilities in:
- Ensuring consistency and reliability across different liquid biopsy assays by implementing standardized protocols, quality control measures, and proficiency testing to ensure accuracy and reproducibility of results
- Improving the sensitivity and specificity of liquid biopsy assays to detect low-abundance biomarkers and reducing false positives/negatives
- Developing robust data analysis pipelines and software tools tailored to liquid biopsy applications, enabling more accurate interpretation of results and actionable insights for clinicians and researchers
- Validating liquid biopsy assays for clinical use and ensuring compliance with regulatory requirements (e.g., FDA approval)